Complement receptor 2

Complement receptor 2
Нинди таксонда бар H. sapiens[1]
Кодлаучы ген Рецептор комплемента 2-го типа[d][1]
Молекуляр функция ДНК-связывающий[d][2], гомодимеризация белка[d][3], virus receptor activity[d][4], complement binding[d][5], transmembrane signaling receptor activity[d][6], complement receptor activity[d][7][6] һәм связывание с белками плазмы[d][8]
Күзәнәк компоненты мембрана өлеше[d][6][4], мембрана[d][4], receptor complex[d][9], экзосома[d][10], күзәнәк мембранасы[d][11][12], экзосома[d][13] һәм күзәнәк мембранасы[d][4][7][4]
Биологик процесс процесс иммунной системы[d][4], B cell proliferation[d][14], иммун җавап[d][6], Классический путь активации системы комплемента[d][4], viral entry into host cell[d][4], B cell differentiation[d][14], врождённый иммунитет[d][4], вирусный процесс[d][4], complement receptor mediated signaling pathway[d][4], передача сигнала[d][11] һәм regulation of complement activation[d][4]
Изображение Gene Atlas

Complement receptor 2 (ингл. ) — аксымы, шул ук исемдәге ген тарафыннан кодлана торган югары молекуляр органик матдә.[15][16]

Искәрмәләр

  1. 1,0 1,1 UniProt
  2. Holers V. M., Szakonyi G., Asokan R. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE), Human complement receptor 2 (CR2/CD21) as a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE) // Molecular ImmunologyElsevier, 2013. — 12 p. — ISSN 0161-5890; 1872-9142doi:10.1016/J.MOLIMM.2012.07.002PMID:22885687
  3. Holers V. M., Boackle S. A. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein, Cr2, a Candidate Gene in the Murine Sle1c Lupus Susceptibility Locus, Encodes a Dysfunctional Protein // ImmunityCell Press, Elsevier, 2001. — ISSN 1074-7613; 1097-4180doi:10.1016/S1074-7613(01)00228-XPMID:11728339
  4. 4,00 4,01 4,02 4,03 4,04 4,05 4,06 4,07 4,08 4,09 4,10 4,11 GOA
  5. L Clemenza, Isenman D. E. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21) // J. Immunol.Baltimore: 2000. — ISSN 0022-1767; 1550-6606doi:10.4049/JIMMUNOL.165.7.3839PMID:11034390
  6. 6,0 6,1 6,2 6,3 Moore M. D., Cooper N. R., Tack B. F. et al. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes // Proc. Natl. Acad. Sci. U.S.A. / M. R. Berenbaum[Washington, etc.], USA: National Academy of Sciences [etc.], 1987. — ISSN 0027-8424; 1091-6490doi:10.1073/PNAS.84.24.9194PMID:2827171
  7. 7,0 7,1 Harley J. B., Holers V. M. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor // J. Biol. Chem. / L. M. GieraschBaltimore [etc.]: American Society for Biochemistry and Molecular Biology, 1989. — ISSN 0021-9258; 1083-351X; 1067-8816PMID:2563370
  8. M Barel, M Balbo, A Gauffre et al. Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein // Molecular ImmunologyElsevier, 1995. — ISSN 0161-5890; 1872-9142doi:10.1016/0161-5890(95)00005-YPMID:7753047
  9. Ghai R., Coulson E. J., Collins B. M. et al. Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins // Proc. Natl. Acad. Sci. U.S.A. / M. R. Berenbaum[Washington, etc.], USA: National Academy of Sciences [etc.], 2013. — ISSN 0027-8424; 1091-6490doi:10.1073/PNAS.1216229110PMID:23382219
  10. Buschow S. I., Stoorvogel W., Wauben M. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis // Immunology & Cell BiologyWiley, 2010. — ISSN 0818-9641; 1440-1711doi:10.1038/ICB.2010.64PMID:20458337
  11. 11,0 11,1 GOA
  12. Harley J. B., Holers V. M. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor // J. Biol. Chem. / L. M. GieraschBaltimore [etc.]: American Society for Biochemistry and Molecular Biology, 1989. — ISSN 0021-9258; 1083-351X; 1067-8816PMID:2563370
  13. Buschow S. I., Stoorvogel W., Wauben M. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis // Immunology & Cell BiologyWiley, 2010. — ISSN 0818-9641; 1440-1711doi:10.1038/ICB.2010.64PMID:20458337
  14. 14,0 14,1 GR N., ME M., NR C. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes // J. Immunol.Baltimore: 1985. — ISSN 0022-1767; 1550-6606PMID:2995485
  15. HUGO Gene Nomenclature Commitee, HGNC:29223 (ингл.). әлеге чыганактан 2015-10-25 архивланган. 18 сентябрь, 2017 тикшерелгән.
  16. UniProt, Q9ULJ7 (ингл.). 18 сентябрь, 2017 тикшерелгән.

Чыганаклар

  • Степанов В.М. (2005). Молекулярная биология. Структура и функция белков. Москва: Наука. ISBN 5-211-04971-3.(рус.)
  • Bruce Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, Peter Walter (2002). Molecular Biology of the Cell (вид. 4th). Garland. ISBN 0815332181.(ингл.)


Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.